| Diabetic specific aspects in antithrombotic therapy in patients with coronary artery disease. | |
| | |
MedLine Citation:
|
PMID: 21030936 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
The use of combined antithrombotic medication in optimal dosages is mandatory for diabetic patients. Moreover, specific antiplatelet therapy in DM has been shown to reduce early and late atherothrombotic events in patients referred for elective and acute angiography and intervention as well as for secondary prevention of recurrent ischemic events in patients with coronary artery disease (CAD). Among these antiplatelet agents prasugrel has been recently demonstrated to lower adverse events in diabetic patients with acute coronary syndromes (ACS) significantly more effective than clopidogrel without increasing severe bleeding hazards. Also glycoprotein IIb-IIIa receptor inhibitors (GPI) had a greater effect in diabetic subjects with ACS undergoing percutaneous coronary intervention (PCI) on adverse clinical events compared to non-diabetics. In contrast to antiplatelet therapy, all commercially available antithrombins except enoxaparin have been shown to be equal or less effective in diabetics compared to non-diabetics. Enoxaparin was superior to unfractionated heparin (UFH) in reducing adverse events in diabetics with acute ST-elevation myocardial infarction (STEMI) undergoing thrombolytic therapy. The role of several new antithrombins, i.e. direct factor Xa inhibitors or direct antithrombins in diabetic patients with stable or unstable CAD is still under investigation. |
| | |
Authors:
|
S Farhan; T Höchtl; J Wojta; K Huber |
Related Documents
:
|
15588436 - Haptoglobin phenotype as a predictive factor of mortality in diabetic haemodialysis pat... 20614496 - Are diabetic patients less likely to feel angina than nondiabetic controls for a given ... 15366696 - Hypothesis: normalisation of cytokine dysbalance explains the favourable effects of str... 21030006 - Treatment of type 2 diabetes: new clinical studies and effects of glp-1 on macrovascula... 11563846 - Tnfalpha inhibits insulin's antiapoptotic signaling in vascular smooth muscle cells. 2111786 - Human antral damage induced by alcohol is potentiated by enprostil. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Minerva medica Volume: 101 ISSN: 0026-4806 ISO Abbreviation: Minerva Med. Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-10-29 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0400732 Medline TA: Minerva Med Country: Italy |
Other Details:
|
Languages: eng Pagination: 239-53 Citation Subset: IM |
Affiliation:
|
Department of Medicine, Cardiology and Emergency Medicine, Wilhelminen Hospital, Vienna, Austria. serdar.farhan@wienkav.at |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Antithrombotic treatment in acute coronary syndromes.
Next Document: Young at heart. An update on cardiac regeneration.